BMS-488043

anti-HIV agent

Also Known As:

1,2-ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridin-3-yl)-; 1-(4-benzoyl-1-piperazinyl)-2-(4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridin-3-yl)-1,2-ethanedione

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - BMS-488043: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - BMS-488043: 1
Organic Chemicals: 133
- Carboxylic Acids: 973
  - Keto Acids: 203
    - Pyruvates: 20
      - Pyruvic Acid: 4808
        BMS-488043: 1

Experts

1.	Clapham, Paul: 1 article (04/2006)
2.	Colonno, Richard: 1 article (04/2006)
3.	Dalterio, Richard: 1 article (04/2006)
4.	Dicker, Ira: 1 article (04/2006)
5.	Fan, Li: 1 article (04/2006)
6.	Fang, Hua: 1 article (04/2006)
7.	Gong, Yi-Fei: 1 article (04/2006)
8.	Ho, Hsu-Tso: 1 article (04/2006)
9.	Kadow, John: 1 article (04/2006)
10.	Li, Chang-Ben: 1 article (04/2006)

Related Diseases

1.	Virus Diseases (Viral Diseases) 04/01/2006 - "However, BMS-488043 could only partially inhibit CD4 binding to an HIV variant containing a specific envelope truncation and altered gp120 conformation, despite effectively inhibiting the pseudotyped virus infection. "